SCHEMBL20109134

SCHEMBL20109134

C=C(C(C)C)P1(=O)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
ATM Q13315 2/20 0.33
XBP1 P17861 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HTR2C P28335 1/20 0.32
CYP2D6 P10635 1/20 0.32
ALDH1A1 P00352 4/20 0.31
KDM4E B2RXH2 2/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
GFER P55789 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
GAA P10253 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109150 0.86 CYP2D6 (0.36) SMN1; SMN2LMNAATMNPC1RAB9A
SCHEMBL20109131 0.81 CYP2C19 (0.35) SMN1; SMN2LMNAMAPTNPSR1ALDH1A1
SCHEMBL17596724 0.80 KMT2A (0.34) LMNAMAPTNPSR1NPC1RAB9A
SCHEMBL20109243 0.80 SIGMAR1 (0.32) LMNAATMCYP2D6ALDH1A1KDM4E
SCHEMBL20109215 0.80 ATM (0.33) LMNAMAPTATMCYP2D6ALDH1A1
SCHEMBL17596436 0.79 GAA (0.39) SMN1; SMN2LMNAMAPTNPC1RAB9A
SCHEMBL20109140 0.77 CHRNA7 (0.36) LMNAMAPTNPSR1NPC1RAB9A
SCHEMBL20109145 0.76 ALDH1A1 (0.41) SMN1; SMN2MAPTATMNPC1RAB9A
SCHEMBL20109272 0.75 GAA (0.40) LMNAMAPTNPC1MEN1KMT2A
SCHEMBL17596810 0.74 MMP8 (0.48) SMN1; SMN2LMNAMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 DHODH 1804/4885SMN1; SMN2 3047/4885LMNA 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.